Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors

ASCO and SNO endorsement of the congress of neurological surgeons guidelines

Susan M. Chang, Hans Messersmith, Manmeet Ahluwalia, David Andrews, Priscilla K. Brastianos, Laurie E. Gaspar, Na Tosha N. Gatson, Justin T. Jordan, Mustafa Khasraw, Andrew B. Lassman, Julia Maues, Maciej Mrugala, Jeffrey Raizer, David Schiff, Glen, Do, Phd Stevens, Ashley Sumrall, Martin Van Den Bent, Michael A. Vogelbaum

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

PURPOSE The Congress of Neurological Surgeons (CNS) has developed a series of guidelines for the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS Two CNS guidelines were reviewed for developmental rigor by methodologists, and an independent multidisciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The Expert Panel voted to endorse the two guidelines, and ASCO and Society for Neuro-Oncology (SNO) independently reviewed and approved the ASCO/SNO guideline endorsement. RESULTS The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based on the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines with minor alterations. RECOMMENDATIONS Key recommendations include the following: prophylactic antiepileptic drugs were not recommended for routine use; and corticosteroids, specifically dexamethasone, were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases. Additional information is available at www.asco.org/neurooncology-guidelines.

Original languageEnglish (US)
Pages (from-to)1130-1135
Number of pages6
JournalJournal of Clinical Oncology
Volume37
Issue number13
DOIs
StatePublished - Jan 1 2019

Fingerprint

Brain Neoplasms
Anticonvulsants
Steroids
Guidelines
Neurologic Manifestations
Neurosurgeons
Practice Guidelines
Dexamethasone
Adrenal Cortex Hormones
Neoplasm Metastasis
Brain
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors : ASCO and SNO endorsement of the congress of neurological surgeons guidelines. / Chang, Susan M.; Messersmith, Hans; Ahluwalia, Manmeet; Andrews, David; Brastianos, Priscilla K.; Gaspar, Laurie E.; Gatson, Na Tosha N.; Jordan, Justin T.; Khasraw, Mustafa; Lassman, Andrew B.; Maues, Julia; Mrugala, Maciej; Raizer, Jeffrey; Schiff, David; Stevens, Glen, Do, Phd; Sumrall, Ashley; Van Den Bent, Martin; Vogelbaum, Michael A.

In: Journal of Clinical Oncology, Vol. 37, No. 13, 01.01.2019, p. 1130-1135.

Research output: Contribution to journalReview article

Chang, SM, Messersmith, H, Ahluwalia, M, Andrews, D, Brastianos, PK, Gaspar, LE, Gatson, NTN, Jordan, JT, Khasraw, M, Lassman, AB, Maues, J, Mrugala, M, Raizer, J, Schiff, D, Stevens, GDP, Sumrall, A, Van Den Bent, M & Vogelbaum, MA 2019, 'Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines', Journal of Clinical Oncology, vol. 37, no. 13, pp. 1130-1135. https://doi.org/10.1200/JCO.18.02085
Chang, Susan M. ; Messersmith, Hans ; Ahluwalia, Manmeet ; Andrews, David ; Brastianos, Priscilla K. ; Gaspar, Laurie E. ; Gatson, Na Tosha N. ; Jordan, Justin T. ; Khasraw, Mustafa ; Lassman, Andrew B. ; Maues, Julia ; Mrugala, Maciej ; Raizer, Jeffrey ; Schiff, David ; Stevens, Glen, Do, Phd ; Sumrall, Ashley ; Van Den Bent, Martin ; Vogelbaum, Michael A. / Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors : ASCO and SNO endorsement of the congress of neurological surgeons guidelines. In: Journal of Clinical Oncology. 2019 ; Vol. 37, No. 13. pp. 1130-1135.
@article{3bda9bf11e314788a9ad555bde1c5563,
title = "Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines",
abstract = "PURPOSE The Congress of Neurological Surgeons (CNS) has developed a series of guidelines for the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS Two CNS guidelines were reviewed for developmental rigor by methodologists, and an independent multidisciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The Expert Panel voted to endorse the two guidelines, and ASCO and Society for Neuro-Oncology (SNO) independently reviewed and approved the ASCO/SNO guideline endorsement. RESULTS The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based on the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines with minor alterations. RECOMMENDATIONS Key recommendations include the following: prophylactic antiepileptic drugs were not recommended for routine use; and corticosteroids, specifically dexamethasone, were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases. Additional information is available at www.asco.org/neurooncology-guidelines.",
author = "Chang, {Susan M.} and Hans Messersmith and Manmeet Ahluwalia and David Andrews and Brastianos, {Priscilla K.} and Gaspar, {Laurie E.} and Gatson, {Na Tosha N.} and Jordan, {Justin T.} and Mustafa Khasraw and Lassman, {Andrew B.} and Julia Maues and Maciej Mrugala and Jeffrey Raizer and David Schiff and Stevens, {Glen, Do, Phd} and Ashley Sumrall and {Van Den Bent}, Martin and Vogelbaum, {Michael A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1200/JCO.18.02085",
language = "English (US)",
volume = "37",
pages = "1130--1135",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "13",

}

TY - JOUR

T1 - Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors

T2 - ASCO and SNO endorsement of the congress of neurological surgeons guidelines

AU - Chang, Susan M.

AU - Messersmith, Hans

AU - Ahluwalia, Manmeet

AU - Andrews, David

AU - Brastianos, Priscilla K.

AU - Gaspar, Laurie E.

AU - Gatson, Na Tosha N.

AU - Jordan, Justin T.

AU - Khasraw, Mustafa

AU - Lassman, Andrew B.

AU - Maues, Julia

AU - Mrugala, Maciej

AU - Raizer, Jeffrey

AU - Schiff, David

AU - Stevens, Glen, Do, Phd

AU - Sumrall, Ashley

AU - Van Den Bent, Martin

AU - Vogelbaum, Michael A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - PURPOSE The Congress of Neurological Surgeons (CNS) has developed a series of guidelines for the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS Two CNS guidelines were reviewed for developmental rigor by methodologists, and an independent multidisciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The Expert Panel voted to endorse the two guidelines, and ASCO and Society for Neuro-Oncology (SNO) independently reviewed and approved the ASCO/SNO guideline endorsement. RESULTS The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based on the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines with minor alterations. RECOMMENDATIONS Key recommendations include the following: prophylactic antiepileptic drugs were not recommended for routine use; and corticosteroids, specifically dexamethasone, were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases. Additional information is available at www.asco.org/neurooncology-guidelines.

AB - PURPOSE The Congress of Neurological Surgeons (CNS) has developed a series of guidelines for the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS Two CNS guidelines were reviewed for developmental rigor by methodologists, and an independent multidisciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The Expert Panel voted to endorse the two guidelines, and ASCO and Society for Neuro-Oncology (SNO) independently reviewed and approved the ASCO/SNO guideline endorsement. RESULTS The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based on the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines with minor alterations. RECOMMENDATIONS Key recommendations include the following: prophylactic antiepileptic drugs were not recommended for routine use; and corticosteroids, specifically dexamethasone, were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases. Additional information is available at www.asco.org/neurooncology-guidelines.

UR - http://www.scopus.com/inward/record.url?scp=85063717455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063717455&partnerID=8YFLogxK

U2 - 10.1200/JCO.18.02085

DO - 10.1200/JCO.18.02085

M3 - Review article

VL - 37

SP - 1130

EP - 1135

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 13

ER -